TSS
PRAX icon

Two Sigma Securities’s Praxis Precision Medicines PRAX Stock Holding History

Two Sigma Securities’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Buy
+793
New +$251K 0.02% 963

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Securities's PRAX Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 793 shares worth $265K. The stake represents 0.02% of the portfolio and ranks #963 among its holdings.

309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Two Sigma Securities held 793 shares of Praxis Precision Medicines worth $265K as of Q2 2026.
  • Praxis Precision Medicines was a new Two Sigma Securities position in Q2 2026.
  • Praxis Precision Medicines made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #963 holding.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.